HW
ATRS

Hancock Whitney’s Antares Pharma, Inc. ATRS Stock Holding History

Hancock Whitney’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-42,743
Closed -$186K – 843
2021
Q2 		$186K Buy
42,743
+210
+0.5% +$855 0.01% 769
2021
Q1 		$175K Hold
42,533
– – 0.01% 736
2020
Q4 		$170K Hold
42,533
– – 0.01% 749
2020
Q3 		$115K Buy
+42,533
New +$118K ﹤0.01% 738

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Hancock Whitney's ATRS Position: Q3 2021 in Review

Hancock Whitney sold out of Antares Pharma, Inc. (ATRS) in Q3 2021, closing a stake of 42,743 shares — an estimated $186K sold.

Hancock Whitney first reported a position in ATRS in Q3 2020 and held it in 4 quarters. The position peaked at $186K in Q2 2021. 170 funds tracked by Wall St. Rank hold ATRS as of Q3 2021.

  • Hancock Whitney reported no remaining Antares Pharma, Inc. position as of Q3 2021 after selling out during the quarter.
  • Hancock Whitney sold 42,743 Antares Pharma, Inc. shares in Q3 2021, an estimated $186K.
  • Hancock Whitney first reported a position in Antares Pharma, Inc. in Q3 2020 and held it in 4 quarters.
  • Hancock Whitney's Antares Pharma, Inc. position peaked at $186K in Q2 2021.
  • 170 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2021.

Based on Hancock Whitney's 13F filing for Q3 2021, filed 4 Nov 2021.